HOP S. TRAN CAO to Cholangiocarcinoma
This is a "connection" page, showing publications HOP S. TRAN CAO has written about Cholangiocarcinoma.
Connection Strength
5.075
-
Great Debates: Neoadjuvant Therapy Should be Routinely Given for High-Risk Cholangiocarcinoma. Ann Surg Oncol. 2023 12; 30(13):7960-7965.
Score: 0.752
-
Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma - does pathologic response mean better outcomes? HPB (Oxford). 2023 04; 25(4):472-480.
Score: 0.720
-
Lymphadenectomy and margin-negative resection for biliary tract cancer surgery in the United States-Differential technical performance by approach. J Surg Oncol. 2022 Sep; 126(4):658-666.
Score: 0.686
-
Time to Rethink Upfront Surgery for Resectable Intrahepatic Cholangiocarcinoma? Implications from the Neoadjuvant Experience. Ann Surg Oncol. 2021 Oct; 28(11):6725-6735.
Score: 0.629
-
ASO Author Reflections: Role of Neoadjuvant Therapy in Surgically Resectable Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2021 10; 28(11):6736-6737.
Score: 0.626
-
Portal Vein Embolization for Perihilar Cholangiocarcinoma: A Story Worth Repeating. Ann Surg Oncol. 2020 Jul; 27(7):2120-2121.
Score: 0.589
-
The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts. Cancer. 2018 Jan 01; 124(1):74-83.
Score: 0.495
-
Revisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress? Ann Surg Oncol. 2024 May; 31(5):3062-3068.
Score: 0.193
-
Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis. Oncologist. 2023 04 06; 28(4):327-332.
Score: 0.182
-
Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States. Cancer. 2022 07 01; 128(13):2529-2539.
Score: 0.170
-
Hospital Minimally Invasive Surgery Utilization for Gastrointestinal Cancer. Ann Surg. 2018 08; 268(2):303-310.
Score: 0.033